Research Articles | Page 90 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the Europ Jun 2016 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia Jan 2019 Biol Blood Marrow Transplant aplastic anemia
Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myeloid leukemia following aplastic anemia Dec 2013 Biol Blood Marrow Transplant aplastic anemia
Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research Aug 2012 Biol Blood Marrow Transplant aplastic anemia
Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria Apr 2012 BioDrugs paroxysmal nocturnal hemoglobinuria (PNH)
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis. Mar 2013 Biochem Cell Biol myelodysplastic syndromes (MDS)
Clonal Hematopoiesis and therapy related MDS/AML Mar 2019 Best Practice & Research. Clinical Heamatology myelodysplastic syndromes (MDS)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? May 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Share with addtoany.com.